Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05849259 · ClinicalTrials.gov registry record · NA

Caring for Caregivers and People Living With Dementia Under Home-Based Primary Care

A NA study, sponsored by Massachusetts General Hospital.

Completed
Registry status
NA
Development phase
50
Enrollment target

NCT05849259: Completed NA study, sponsored by Massachusetts General Hospital.

NCT05849259 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05849259, a NA study, has completed, sponsored by Massachusetts General Hospital.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target

Study Summary

The goal of this clinical trial is to develop a dementia care intervention for persons receiving home-based primary care (HBPC) and living with dementia (PLWD) and their caregivers, and test the feasibility of implementing the intervention in HBPC practices to ultimately improve outcomes of PLWD and their caregivers. The main aims are to: * Develop and refine HBPC Dementia Care Quality at Home * Establish feasibility (primary outcome), acceptability, and fidelity of HBPC Dementia Care Quality at Home through an open-pilot trial involving two HBPC practices. Trained clinicians and staff at two HBPC practices will implement the intervention Relevant stakeholders (caregivers of PLWD, and HBPC clinicians and staff) will participate in qualitative focus groups to provide feedback on the intervention.

Interventions

  • OTHER Dementia Care Quality at Home

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2023-10-16
Est. Completion 2024-12-20
Phase NA

Sponsor

Massachusetts General Hospital

2,032 total trials

What the Registry Record Tells You About NCT05849259

The ClinicalTrials.gov registry entry for NCT05849259 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Massachusetts General Hospital, which has 2,032 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Dementia Care Quality at Home is the first listed.

NCT05849259 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05849259 about?

NCT05849259 is a clinical study titled "Caring for Caregivers and People Living With Dementia Under Home-Based Primary Care". The goal of this clinical trial is to develop a dementia care intervention for persons receiving home-based primary care (HBPC) and living with dementia (PLWD) and their caregivers, and test the feasibility of implementing the intervention in HBPC practices to ultimately improve outcomes of PLWD and...

What is the current status of trial NCT05849259?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2023-10-16. Estimated completion is 2024-12-20.

What interventions are being tested in trial NCT05849259?

The interventions under investigation include: Dementia Care Quality at Home (OTHER).

Who is sponsoring clinical trial NCT05849259?

This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.